Quick Answer
Phio Pharmaceuticals Corp. reported Long-Term Debt of $0.00 for fiscal year 2021.
Phio Pharmaceuticals Corp. Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2021 | $0.00 | -100.0% |
| 2020 | $231.0K | — |
| 2019 | $0.00 | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| September 30, 2021 | $0.00 | -100.0% | — |
| June 30, 2021 | $0.00 | -100.0% | — |
| March 31, 2021 | $0.00 | — | -100.0% |
| December 31, 2020 | $231.0K | — | +0.0% |
| September 30, 2020 | $231.0K | — | +0.0% |
| June 30, 2020 | $231.0K | — | — |
| December 31, 2019 | $0.00 | — | — |
- Phio Pharmaceuticals Corp. showed a decrease of -100.0% in Long-Term Debt compared to the prior fiscal year.
- The most recent figure is from Phio Pharmaceuticals Corp.’s fiscal year 2021 report (Form 10-K), filed with the SEC on March 22, 2022.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: